(2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide

C49H96N2O10 — CID 10033591

IUPAC(2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide
SMILESCCCCCCCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@H](O)[C@H](O)CCCCCCCCCCCCC(C)C
InChIInChI=1S/C49H96N2O10/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23-26-29-32-35-42(55)48(59)51-40(37-60-49-44(50-39(4)53)47(58)46(57)43(36-52)61-49)45(56)41(54)34-31-28-25-22-20-19-21-24-27-30-33-38(2)3/h38,40-47,49,52,54-58H,5-37H2,1-4H3,(H,50,53)(H,51,59)/t40-,41+,42+,43+,44+,45-,46+,47+,49+/m0/s1
InChIKeyJIULYTZUDMNSDU-UBQTUZBJSA-N
MW873.31 g/mol
LogP8.28
Rot. Bonds41

About (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide

(2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide (PubChem CID 10033591) has the molecular formula C49H96N2O10 and a molecular weight of 873.31 g/mol. Its IUPAC name is (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide.

Molecular Properties

Compound Name(2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide
PubChem CID10033591
Molecular FormulaC49H96N2O10
Molecular Weight873.31 g/mol
Exact Mass872.71
IUPAC Name(2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide
SMILESCCCCCCCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@H](O)[C@H](O)CCCCCCCCCCCCC(C)C
InChIInChI=1S/C49H96N2O10/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23-26-29-32-35-42(55)48(59)51-40(37-60-49-44(50-39(4)53)47(58)46(57)43(36-52)61-49)45(56)41(54)34-31-28-25-22-20-19-21-24-27-30-33-38(2)3/h38,40-47,49,52,54-58H,5-37H2,1-4H3,(H,50,53)(H,51,59)/t40-,41+,42+,43+,44+,45-,46+,47+,49+/m0/s1
InChIKeyJIULYTZUDMNSDU-UBQTUZBJSA-N
XLogP8.28
TPSA198.04 Ų
H-Bond Donors8
H-Bond Acceptors10
Rotatable Bonds41
Heavy Atoms61
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500873.31
LogP ≤ 58.28
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide?
The IUPAC name of (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide (CID 10033591) is (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide.
What is the SMILES notation for (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide?
The canonical SMILES for (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide is CCCCCCCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@H](O)[C@H](O)CCCCCCCCCCCCC(C)C.
What is the InChIKey of (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide?
The InChIKey is JIULYTZUDMNSDU-UBQTUZBJSA-N. The full InChI is InChI=1S/C49H96N2O10/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23-26-29-32-35-42(55)48(59)51-40(37-60-49-44(50-39(4)53)47(58)46(57)43(36-52)61-49)45(56)41(54)34-31-28-25-22-20-19-21-24-27-30-33-38(2)3/h38,40-47,49,52,54-58H,5-37H2,1-4H3,(H,50,53)(H,51,59)/t40-,41+,42+,43+,44+,45-,46+,47+,49+/m0/s1.
What are the key properties of (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide?
(2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide has a molecular weight of 873.31 g/mol, XLogP of 8.28, 41 rotatable bonds, 8 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[(2S,3S,4R)-1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-17-methyloctadecan-2-yl]-2-hydroxydocosanamide is sourced from PubChem (CID 10033591), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).